These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 11300654)
1. Modulation of human platelet aggregation by the phosphodiesterase type 5 inhibitor sildenafil. Berkels R; Klotz T; Sticht G; Englemann U; Klaus W J Cardiovasc Pharmacol; 2001 Apr; 37(4):413-21. PubMed ID: 11300654 [TBL] [Abstract][Full Text] [Related]
2. Sildenafil potentiates nitric oxide mediated inhibition of human platelet aggregation. Gudmundsdóttir IJ; McRobbie SJ; Robinson SD; Newby DE; Megson IL Biochem Biophys Res Commun; 2005 Nov; 337(1):382-5. PubMed ID: 16185664 [TBL] [Abstract][Full Text] [Related]
3. Effects of sildenafil (viagra) on human myocardial contractility, in vitro arrhythmias, and tension of internal mammaria arteries and saphenous veins. Cremers B; Scheler M; Maack C; Wendler O; Schäfers HJ; Südkamp M; Böhm M J Cardiovasc Pharmacol; 2003 May; 41(5):734-43. PubMed ID: 12717104 [TBL] [Abstract][Full Text] [Related]
4. Nitric oxide donors and angiotensin-converting enzyme inhibitors act in concert to inhibit human angiotensin-converting enzyme activity and platelet aggregation in vitro. Persson K; Whiss PA; Nyhlén K; Jacobsson-Strier M; Glindell M; Andersson RG Eur J Pharmacol; 2000 Oct; 406(1):15-23. PubMed ID: 11011027 [TBL] [Abstract][Full Text] [Related]
5. Effects of sildenafil citrate on human hemodynamics. Jackson G; Benjamin N; Jackson N; Allen MJ Am J Cardiol; 1999 Mar; 83(5A):13C-20C. PubMed ID: 10078538 [TBL] [Abstract][Full Text] [Related]
6. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase. Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591 [TBL] [Abstract][Full Text] [Related]
7. Adenosine 5'-diphosphate-induced platelet aggregation in uremia shows resistance to inhibition by the novel nitric oxide donor GEA 3175 but not by S-nitroso-N-acetylpenicillamine. Whiss PA; Larsson R Haemostasis; 1998; 28(5):260-7. PubMed ID: 10420076 [TBL] [Abstract][Full Text] [Related]
8. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist. Webb DJ; Freestone S; Allen MJ; Muirhead GJ Am J Cardiol; 1999 Mar; 83(5A):21C-28C. PubMed ID: 10078539 [TBL] [Abstract][Full Text] [Related]
9. Relaxation effect of nitric oxide-donor on diabetic penile smooth muscle in vitro. Taher A; Birowo P; Kamil ST; Shahab N Clin Hemorheol Microcirc; 2000; 23(2-4):277-81. PubMed ID: 11321451 [TBL] [Abstract][Full Text] [Related]
10. Sildenafil improves coronary artery patency in a canine model of platelet-mediated cyclic coronary occlusion after thrombolysis. Lewis GD; Witzke C; Colon-Hernandez P; Guerrero JL; Bloch KD; Semigran MJ J Am Coll Cardiol; 2006 Apr; 47(7):1471-7. PubMed ID: 16580539 [TBL] [Abstract][Full Text] [Related]
11. Endothelial cells play an important role in the antiaggregatory effect of nitric oxide. Klinge JM; Topf HG; Trusen B; Rauh M; Rascher W; Dötsch J Crit Care Med; 2003 Jul; 31(7):2010-4. PubMed ID: 12847397 [TBL] [Abstract][Full Text] [Related]
12. The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia. Halcox JP; Nour KR; Zalos G; Mincemoyer RA; Waclawiw M; Rivera CE; Willie G; Ellahham S; Quyyumi AA J Am Coll Cardiol; 2002 Oct; 40(7):1232-40. PubMed ID: 12383570 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms. Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301 [TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide. Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190 [TBL] [Abstract][Full Text] [Related]
15. Antimitogenic actions of organic nitrates are potentiated by sildenafil and mediated via activation of protein kinase A. Osinski MT; Rauch BH; Schrör K Mol Pharmacol; 2001 May; 59(5):1044-50. PubMed ID: 11306686 [TBL] [Abstract][Full Text] [Related]
16. KF31327, a new potent and selective inhibitor of cyclic nucleotide phosphodiesterase 5. Hirose R; Okumura H; Yoshimatsu A; Irie J; Onoda Y; Nomoto Y; Takai H; Ohno T; Ichimura M Eur J Pharmacol; 2001 Nov; 431(1):17-24. PubMed ID: 11716838 [TBL] [Abstract][Full Text] [Related]
18. A nitric oxide-releasing PDE5 inhibitor relaxes human corpus cavernosum in the absence of endogenous nitric oxide. Kalsi JS; Ralph DJ; Thomas P; Bellringer J; Minhas S; Kell PD; Cellek S J Sex Med; 2005 Jan; 2(1):53-7. PubMed ID: 16422907 [TBL] [Abstract][Full Text] [Related]
19. The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5. Dunkern TR; Hatzelmann A Cell Signal; 2005 Mar; 17(3):331-9. PubMed ID: 15567064 [TBL] [Abstract][Full Text] [Related]
20. Nitric oxide and platelet energy metabolism. Tomasiak M; Stelmach H; Rusak T; Wysocka J Acta Biochim Pol; 2004; 51(3):789-803. PubMed ID: 15448739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]